Fig. 3.

Effect of fisetin on SCI-induced alterations in NF-κB (a) and IκBα (b) protein expressions. Data are expressed as mean ± SEM (n = 6) and analyzed by two-way ANOVA followed by Bonferroni’s test. *P < 0.05 as compared to SCI control group, ^#P < 0.05 as compared with sham group, ^&P < 0.05 as compared with normal and ^$p < 0.05 as compared with one another. ANOVA, analysis of variance; IκBα, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-alpha; NF-κB, nuclear factor kappa B; SCI, spinal cord injury.